X-74591451-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_016120.4(RLIM):c.1864A>G(p.Ser622Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016120.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RLIM | ENST00000332687.11 | c.1864A>G | p.Ser622Gly | missense_variant | Exon 4 of 4 | 1 | NM_016120.4 | ENSP00000328059.6 | ||
RLIM | ENST00000349225.2 | c.1864A>G | p.Ser622Gly | missense_variant | Exon 5 of 5 | 2 | ENSP00000253571.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000183 AC: 2AN: 1093316Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 358994
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1864A>G (p.S622G) alteration is located in exon 5 (coding exon 3) of the RLIM gene. This alteration results from an A to G substitution at nucleotide position 1864, causing the serine (S) at amino acid position 622 to be replaced by a glycine (G). Based on data from the Genome Aggregation Database (gnomAD), the RLIM c.1864A>G alteration was not observed, with coverage at this position. This alteration has been reported de novo once from a cohort of fetuses with abnormalities detected on ultrasound. The affected fetus was reported with subependymal nodules in the left ventricle and mild left ventriculomegaly, but further clinical information was not provided (Qi, 2020). The p.S622 amino acid is highly conserved in available vertebrate species. The p.S622G alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.